Halozyme Therapeutics
HALO
$39.12
Share price
0.38%
Change (1 day)
16.64%
Change (1 year)
Categories
Revenue for Halozyme Therapeutics (HALO)
Revenue in 2023 (TTM): $0.82 B
According to Halozyme Therapeutics's latest financial reports the company's current revenue (TTM) is $0.82 B. In 2022 the company made a revenue of $0.66 B an increase over the years 2021 revenue that were of $0.44 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Halozyme Therapeutics from 2002 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.82 B | 25.62% |
| 2022 | $0.66 B | 48.91% |
| 2021 | $0.44 B | 65.67% |
| 2020 | $0.26 B | 36.53% |
| 2019 | $0.19 B | 29.06% |
| 2018 | $0.15 B | -52.04% |
| 2017 | $0.31 B | 115.84% |
| 2016 | $0.14 B | 8.61% |
| 2015 | $0.13 B | 79.28% |
| 2014 | $75.33 M | 37.47% |
| 2013 | $54.79 M | 29.47% |
| 2012 | $42.32 M | -24.54% |
| 2011 | $56.08 M | 311.67% |
| 2010 | $13.62 M | -0.35% |
| 2009 | $13.67 M | 55.99% |
| 2008 | $8.76 M | 130.66% |
| 2007 | $3.79 M | 287.02% |
| 2006 | $0.98 M | |
| 2003 | $0.01 M | -79.78% |
| 2002 | $0.08 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 11,117.57% | 🇺🇸 USA |
 Pfizer PFE | $58.49 B | 6,954.18% | 🇺🇸 USA |
 Eli Lilly LLY | $34.12 B | 4,015.04% | 🇺🇸 USA |
 Sanofi SNY | $50.35 B | 5,972.93% | 🇫🇷 France |
 Baxter BAX | $14.94 B | 1,702.71% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.19 B | -76.01% | 🇺🇸 USA |